Literature DB >> 1576133

Quality of life in patients with advanced heart failure.

K Dracup1, J A Walden, L W Stevenson, M L Brecht.   

Abstract

Although evaluation of the treatment of congestive heart failure is usually based on objective clinical outcomes, patient self-assessment is increasingly recognized as an important component of evaluation. A study was designed to measure the quality of life of 134 patients with symptoms of advanced heart failure who were being evaluated for possible heart transplantation. The patients' quality of life was assessed using a mix of subjective and objective measures, including functional status, physical symptoms, emotional state, and psychosocial adaptation. There was no significant relationship between patients' cardiac ejection fraction and any quality-of-life measures; however, the results of a 6-minute walking test, New York Heart Association classification, and self-reported functional status were all significantly correlated with psychosocial adjustment. Self-reported functional status, depression, and hostility accounted for 43% of the variance in total psychosocial adjustment to illness. These findings support the inclusion of quality of life as an outcome measure in any evaluation of treatment efficacy and suggest that interventions to improve the quality of life of patients with advanced heart failure need to be targeted at reducing depression and hostility and increasing daily activity levels.

Entities:  

Mesh:

Year:  1992        PMID: 1576133

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  54 in total

Review 1.  The need for palliative care in the management of heart failure.

Authors:  Christopher Ward
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

2.  Changes over 6-months in health-related quality of life in a matched sample of Hispanics and non-Hispanics with heart failure.

Authors:  Barbara Riegel; Beverly Carlson; Dale Glaser; Tomas Romero
Journal:  Qual Life Res       Date:  2003-09       Impact factor: 4.147

3.  [Cost effectiveness of bisoprolol in heart failure. Economic evaluation of the Cardiac Insufficiency Bisoprolol Study (CIBIS) for Germany].

Authors:  P K Schädlich; B Paschen; J G Brecht
Journal:  Med Klin (Munich)       Date:  1997-08-15

4.  The psychological consequences of cardiopulmonary resuscitation training for family members of patients at risk for sudden death.

Authors:  K Dracup; D K Moser; S E Taylor; P M Guzy
Journal:  Am J Public Health       Date:  1997-09       Impact factor: 9.308

Review 5.  Heart failure treatments: issues of safety versus issues of quality of life.

Authors:  J Feenstra; J Lubsen; D E Grobbee; B H Stricker
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

6.  What's up in heart failure care in the Netherlands?

Authors:  S de Loor; T Jaarsma
Journal:  Neth Heart J       Date:  2001-09       Impact factor: 2.380

7.  Reliability and construct validity of PROMIS® measures for patients with heart failure who undergo heart transplant.

Authors:  Kathryn E Flynn; Mary Amanda Dew; Li Lin; Maria Fawzy; Felicia L Graham; Elizabeth A Hahn; Ron D Hays; Robert L Kormos; Honghu Liu; Mary McNulty; Kevin P Weinfurt
Journal:  Qual Life Res       Date:  2015-06-03       Impact factor: 4.147

8.  Relative importance and interrelations between psychosocial factors and individualized quality of life of hemodialysis patients.

Authors:  David Tovbin; Yori Gidron; Tzipora Jean; Ricardo Granovsky; Alla Schnieder
Journal:  Qual Life Res       Date:  2003-09       Impact factor: 4.147

9.  Health status and depression remission in patients with chronic heart failure: patient-reported outcomes from the SADHART-CHF trial.

Authors:  Glen L Xiong; Mona Fiuzat; Maragatha Kuchibhatla; Ranga Krishnan; Christopher M O'Connor; Wei Jiang
Journal:  Circ Heart Fail       Date:  2012-10-12       Impact factor: 8.790

10.  Impact of obesity on quality of life and depression in patients with heart failure.

Authors:  Lorraine S Evangelista; Debra K Moser; Cheryl Westlake; Michele A Hamilton; Gregg C Fonarow; Kathleen Dracup
Journal:  Eur J Heart Fail       Date:  2006-03-10       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.